A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV

被引：0
|
作者：
Alfredo Pece
Paolo Milani
Carla Monteleone
Costantino John Trombetta
Giuseppe De Crecchio
Giuseppe Fasolino
Domenica Matranga
Salvatore Cillino
Maria Vadalà
机构：
[1] Ospedale di Melegnano,Unità operativa di Oftalmologia
[2] Fondazione Retina 3000,Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Sezione di Oftalmologia
[3] Università di Palermo,Dipartimento di Specialità Chirurgiche, Sezione di Oftalmologia
[4] Università di Messina,Dipartimento di Scienze Oftalmologiche
[5] Università di Napoli,Dipartimento di Scienze per la Promozione della Salute e Materno Infantile
[6] Retina Center,undefined
[7] Università di Palermo,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2015年 / 253卷
关键词：
Pathological myopia; CNV; Bevacizumab; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1867 / 1872
页数：5
相关论文
共 50 条
  • [31] Effects of Intravitreal Injection of Bevacizumab or Ranibizumab on Systemic Circulation
    Yoon, Myung Hun
    Kim, Young Jun
    Lee, So Young
    Lee, Kang Won
    Chin, Hee Seung
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (03): : 429 - 437
  • [32] SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
    Avery, Robert L.
    Castellarin, Alessandro A.
    Steinle, Nathan C.
    Dhoot, Dilsher S.
    Pieramici, Dante J.
    See, Robert
    Couvillion, Stephen
    Nasir, Ma'an A.
    Rabena, Melvin D.
    Maia, Mauricio
    Van Everen, Sherri
    Le, Kha
    Hanley, William D.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (10): : 1847 - 1858
  • [33] “Oncological” bevacizumab vs. “ophthalmological” ranibizumab: are they both for exudative-neovascular AMD?
    Jerzy Z. Nowak
    Pharmacological Reports, 2011, 63 : 556 - 558
  • [34] "Oncological" bevacizumab vs. "ophthalmological" ranibizumab: are they both for exudative-neovascular AMD?
    Nowak, Jerzy Z.
    PHARMACOLOGICAL REPORTS, 2011, 63 (02) : 556 - 558
  • [35] Prospective Randomised Trial of Intravitreal Bevacizumab vs. Triamcinolone for Patients with Diabetic Macular Edema at the Time of Cataract Surgery (The DiMECAT Trial)
    Lim, Lyndell L.
    Sandhu, Sukhpal Singh
    Constantinou, Marios
    Morrison, Julie
    Wickremasinghe, Sanjeewa
    Kawasaki, Ryo
    Qureshi, Salmaan H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [36] Treatment of high myopic choroidal neovascularisation with intravitreal bevacizumab
    Mathieu, B.
    Isaico, R.
    Ramel, J. -C.
    Bron, A. -M.
    Creuzot-Garcher, C.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2014, 37 (01): : 54 - 57
  • [37] Intravitreal Ranibizumab Injection for the Treatment of Occult and Classic CNV in Exsudative AMD
    Maier, M. M.
    Feucht, N.
    Fegert, C.
    Fiore, B.
    von Mohrenfels, C. Winkler
    Lohmann, C.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2011, 228 (02) : 161 - 167
  • [38] INTRAVITREAL THERAPY WITH RANIBIZUMAB VS AFLIBERCEPT VS BEVACIZUMAB FOR MACULAR OEDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION: A WITHIN TRIAL COST-UTILITY ANALYSIS
    Flight, L.
    Alshreef, A.
    Hykin, P. G.
    Sivaprasad, S.
    Pennington, B.
    Kelly, J.
    Murphy, C. L.
    Brazier, J. E.
    VALUE IN HEALTH, 2019, 22 : S664 - S664
  • [39] Intravitreal bevacizumab for CNV-complicated tilted disk syndrome
    Paolo Milani
    Alfredo Pece
    Giuseppe Moretti
    Pruneri Lino
    Antonio Scialdone
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247 : 1179 - 1182
  • [40] Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis
    Tran, Thi Ha Chau
    Fardeau, Christine
    Terrada, Celine
    Ducos De Lahitte, Ghislaine
    Bodaghi, Bahram
    Lehoang, Phuc
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (12) : 1685 - 1692
12345